Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers

Title
Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers
Authors
Keywords
NSCLC, Doxorubicin resistance, MRP1, P-gp, Hypoxia, HIF-1α
Journal
CELLULAR ONCOLOGY
Volume 39, Issue 5, Pages 411-433
Publisher
Springer Nature
Online
2016-06-15
DOI
10.1007/s13402-016-0285-5

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now